Explore every episode of the podcast On The Pen GLP-1 News
Dive into the complete episode list for On The Pen GLP-1 News. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.
This episode opens the year with one of the most consequential—and complicated—weeks in GLP-1 obesity medicine.
We break down three stories that, taken together, reveal why patients are increasingly reading past headlines and demanding accountability from the industry.
First, we examine early-phase trial data from Arrowhead Pharmaceuticals, after headlines claimed its experimental INHBE-targeting therapy “nearly doubled” the weight loss of Zepbound. We walk through what the data actually showed, why the comparison was misleading, how trial design and dosing matter, and why Phase 1 results should never be treated as superiority claims.
Next, we turn to a major access milestone: the official launch of oral Wegovy, the first FDA-approved GLP-1 pill for obesity from Novo Nordisk. We discuss how this pill differs from compounded oral semaglutide, why its pricing strategy is so disruptive, and what this launch means for people who have avoided injectable medications. We also explore how direct-to-consumer access, telehealth partnerships, and retail pharmacy distribution signal a broader shift in how obesity care is being delivered.
Finally, we address the most ironic—and uncomfortable—story of the week: manufacturing quality concerns involving branded Wegovy pens, reported to include biological particulate matter, at the same time Novo Nordisk continues a years-long public and legal campaign against compounded GLP-1 medications on safety grounds. We discuss FDA inspection history, the acquisition of Catalent, and why credibility depends on consistency—especially when millions of patients are paying close attention.
This episode isn’t anti-pharma or pharma-friendly. It’s patient-first. And it asks a simple question: Who do we trust when science, marketing, access, and manufacturing all collide at once?
Episode Timestamps
00:00 — Why this first episode of 2026 matters 02:10 — Hair found in Wegovy pens and why patients notice hypocrisy 06:15 — Arrowhead trial headlines vs. what the data actually shows 11:40 — Why tirzepatide dosing and trial design matter 17:30 — What INHBE targeting may actually be good for (and what it’s not) 21:45 — Sponsor: SHED and access pathways for obesity care 25:10 — Oral Wegovy officially launches: what’s different this time 30:20 — How the Wegovy pill works and why bioavailability matters 35:40 — Pricing, telehealth, Costco, and direct-to-consumer access 41:50 — Why pills lower barriers for millions of patients 46:10 — Manu
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Wegovy Pill Approved: First Ever GLP-1 Pill, As Good as Injections!
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Lower Cost Zepbound and Wegovy? TrumpRX Announcement Incoming
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90
Dr Spencer Nadolski of the “Docs Who Life” podcast joins Dave to recap obesity week, and to deep dive into Dave’s ongoing struggle with obesity and type 2 diabetes.
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News
In this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This week’s deep dive also touches on emerging trends in GLP-1 therapy and how recent shifts may impact accessibility for patients. Whether you’re just starting your journey or a long-time follower of GLP-1 news, this episode brings you the essentials.
Maritide Bone Density Loss: https://www.statnews.com/2024/11/12/amgen-maritide-obesity-drug-candidate-data/
Catalent Novo Merger: https://www.biospace.com/deals/lilly-vs-novo-the-he-said-she-said-row-about-catalents-glp-1-work
Novo War On Compounds: https://www.onthepen.com/post/shocking-truth-about-semaglutide-what-novo-nordisk-doesn-t-want-you-to-know
Drug Shortage Policy Reform Request (VOTE!): https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Dave brings his analysis of the Q3 Eli Lilly earnings call, and how it relates to the future of access to obesity medicine. Also there is an important clarification on the Zepbound savings card that you should not miss.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
New Zepbound Savings Card, GLP-1 Accessibility Landscape Evolves
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Inside the Legal Battle for Compound Tirzepatide: What You Need to Know from Industry Insider Scott Brunner!
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Tirzepatide Lawsuits Filed By Lilly, Catalent Reframing Novo Merger
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Compounded Zepbound Legal Battle Landscape: Legal Expert Weighs In
OTP legal correspondent Lee (@LeeFitsIn) joins Dave to discuss where we stand in the legal battle over compounded versions of Zepbound and Mounjaro. (Apologies for audio, the interview was a TikTok live recording).
🛒Amazon Affiliate Links (a very small percentage of each sale through these links is commissionable): 💊 DNF-10 Peptide Product Referenced: https://amzn.to/3U9k4Sk 😮💨Ketone Breath Monitor: https://amzn.to/3BGJT5W
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Compounded Zepbound Uncertainty + Leveraging GLP-1 To Improve Labor Shortages
New type two diabetes treatment: https://www.upi.com/Health_News/2024/10/14/ozempic-intestinal-therapy-eliminate-insulin-Type-2-diabetics/6911728911126/
Using GLP-1 to improve workforce participation: https://www.independent.co.uk/news/health/weight-loss-drugs-nhs-tirzepatide-mounjaro-b2629171.html
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Eli Lilly Earnings Call Recap: NEW GLP-1 GIP Peptide Announced!
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Outsourcing Facilities Association Lawsuit: https://www.reuters.com/legal/compounding-group-sues-fda-removing-lillys-weight-loss-drug-shortage-list-2024-10-07/
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Megadosing Zepbound and Mounjaro With Dr. Daniel Rosen
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Ozempic and Zepbound Supply Impacted by Port Worker Strike!
PORT WORKER STRIKE: https://www.cnbc.com/2024/10/01/port-strike-blockbuster-weight-loss-drug-supply-trade-shutdown.html
ZEPBOUND FOR NON-OBESE: https://www.ft.com/content/b2da2ca6-822e-4d42-bee4-e500522531e7
WEIGHT WATCHERS CEO OUT: https://www.bloomberg.com/news/articles/2024-09-27/weightwatchers-replaces-ceo-sima-sistani-after-stock-plummets?leadSource=uverify%20wall
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Amy Kane @AmyInHalf Discusses Dramatic Mounjaro Transformation
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Eli Lilly Compound Tirzepatide Letters + Retatrutide Trial Guest!
We discuss the Eli Lilly letters that are going out to users of compound Tirzepatide. Mimi from the #Retatrutide trial joins! Plus our new segment maintenance minute with Korrie, where Korrie discusses all things weight maintenance! 📺 Watch the Video Version: onthepen.tv 🆕 Discord: https://discord.gg/u4Ea8qqP
🤝 Visit Our Sponsor! Get Connected with Ro Body: https://www.ro.co/otp Report The Shortage: https://www.ro.co/supply-tracker Does your insurance cover GLPs? https://www.ro.com/checker
🥳 Join The Emoji Party! Become a member 🙂: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
📲 Contact Me: dave@onthepen.com
👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen
📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
BCBS Demanding Refunds From Ozempic Prescribers? | The Weekly Dose 9.17.24
Discord: https://discord.gg/QUEp5DBeNew New Facebook Group: https://www.facebook.com/share/g/Ab2ApGdaqRQj1T6c/
Medicare and Ozempic https://qz.com/ozempic-price-cut-medicare-negotiations-1851650680
BCBS Demanding Payments from Off Label Ozempic Prescribers https://www.bloomberg.com/news/articles/2024-09-12/off-label-ozempic-prescriptions-spark-1-million-demand-from-insurer
Visit Our Sponsor! Get Connected with Ro Body: https://www.ro.co/otp Report The Shortage: https://www.ro.co/supply-tracker Does your insurance cover GLPs? https://www.ro.com/checker
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Dr. Spencer Nadolsky On Compound Tirzepatide After Leaving Weight Watchers
Dr. Spencer Nadolsky has announced his departure from Weight Watchers and joins Dave live for a chat about Zepbound GLP1 meds and Obesity medicine.
#WW #WeightWatchers #DrSpencer
Visit Our Sponsor! Get Connected with Ro Body: https://www.ro.co/otp Report The Shortage: https://www.ro.co/supply-tracker Does your insurance cover GLPs? https://www.ro.com/checker
VOTE!! https://www.iowapodcastawards.com/vote
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Ozempic Shortages Extended | The Weekly Dose 9.3.24
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Zepbound Savings Card & Zepbound Vials Discussion With The Downsized
Christopher and Laraine Durham of @TheDownsized join Dave to discuss the Zepbound vials arrival and the changes to the Zepbound savings card!
Visit Our Sponsor! Get Connected with Ro Body: https://www.ro.co/otp Report The Shortage: https://www.ro.co/supply-tracker Does your insurance cover GLPs? https://www.ro.com/checker
VOTE!! https://www.iowapodcastawards.com/vote
WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro BECOME A MEMBER: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro
📲 Contact Me: hello@onthepen.com
📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Madison Muller Article on Zepbound Vial Pricing: https://www.bloomberg.com/news/articles/2024-08-27/eli-lilly-is-now-selling-zepbound-weight-loss-drug-at-50-discount?srnd=undefined
Empoloyer Form Letter to Add Obesity Coverage: https://www.onthepen.com/post/optinforobesity-how-petitioning-your-employer-can-break-the-barriers-to-obesity-treatment
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
#ReleaseTheVials https://www.onthepen.com/post/eli-lilly-to-releasethevials-of-zepbound Eli Lilly has released single-dose vials for ZepBound to stabilize higher dose supplies and removed all Mounjaro and ZepBound doses from the FDA shortage list, though tirzepatide remains in shortage. Novo Nordisk is seeking FDA approval for Icosema, a combination of insulin and semaglutide, with a favorable safety profile.
Patients are encouraged to report ZepBound or Mounjaro shortages to the FDA. Ro has introduced a supply tracker tool to notify patients of nearby availability and launched RoBody, a program connecting patients with doctors to manage obesity and achieve significant weight loss.
Ro's new GLP-1 Insurance Coverage Checker allows users to check insurance coverage for obesity medications and is integrated with the supply tracker. Despite financial struggles, 23andMe is launching a GLP-1 telehealth service. The ‘Opt-in for Obesity’ campaign encourages employees to request obesity coverage from their employers.
On The Pen Live
Z Reitano from Ro will discuss the GLP-1 Insurance Coverage Tool on the upcoming On The Pen Live session, airing on YouTube this Thursday at 9 p.m. Central.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
On The GLP-1 Pen Book Alerts: https://onthepen.com/emails
Gan & Lee (China) https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-bi-weekly-twice-a-month-glp-1-receptor-agonist-gzr18-injection-achieved-17-29-weight-loss-at-30-weeks-in-a-phase-iib-clinical-trial-302202575.html
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Amylin and the future of obesity medicine with Dr. Beverly Tchang
Dave chats with world renowned obesity expert who consults for the likes of Novo Nordisk!
Beverly Tchang, MD is a triple board-certified physician with a focus on obesity medicine. Since 2018, she has been treating patients and training professionals in endocrinology and obesity. Her nationally recognized expertise has led her to extend her knowledge and experience as an advisor to companies, entrepreneurs, and investors who want to learn about modern weight management. BeverlyTchangMD.com X: @bevTchangMD
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Interesting research that shows that type-2 diabetics have more microbiome in their gut that suppresses incretin hormones like GLP-1. This is more evidence that #glp1 medications fix what is biologically broken
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Eli Lilly's phase 2 SYNERGY-NASH study shows tirzepatide effectively resolves MASH and improves fibrosis, offering hope for millions. Read more here: https://www.onthepen.com/post/tirzepatide-shows-promise-in-treating-mash-key-findings-from-the-synergy-nash-study
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Novo Nordisk launches new advertising campaign "The Power of Wegovy"
This advertisement includes the new indication for reduction of cardiovascular risk
For 2023, the #5 advertising spend for a drug was Rybelsus at $191 million. The #6 advertising spend was Ozempic at $187.4 million (increase of 6% from 2022). More than 40% of the 2023 ad spend for Ozempic went to online video platforms (i.e. social media like youtube)
In a 12-week phase 2 clinical study, a tablet formulation of GSBR-1290 had a weight-loss of 6.9%. This is comparable to Eli Lilly's phase 2 results for olforglipron
At Week 12, 67% of GSBR-1290 treated participants achieved ≥6% weight loss and 33% achieved ≥ 10% weight loss, compared to 0% for placebo
Also developing next generation combination GLP-1 candidates together with GIP, amylin, glucagon and apelin oral small molecules
Elon Musk tweeted: Just make a lot of Ozempic/Mounjaro. It’s not inherently expensive. The health benefits of reducing obesity far exceed the downside of GLP-1 inhibitors. We evolved under starving conditions and now make food that is plentiful and delicious. Whether that food is “processed” does matter, but is not a game changer
This tweet has currently been seen 325,500 times
Shanghai Stem Cell Type 2 Diabetes Treatment https://www.scmp.com/news/china/science/article/3263878/chinese-scientists-report-world-first-they-cure-patients-diabetes-cell-therapy
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Zachariah Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health, he joins #OnThePen to talk all things #mounjaro #zepbound #wegovy #ozempic
Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health.
https://ro.co/weight-loss/supply-tracker/
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
GLP-1 usage by young people: From 2020 to 2023, the number of U.S. adolescents and young adults using GLP-1 increased 600 percent — from roughly 8,700 peo
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
On The Pen Live Eps 67: Survodutide Trial Participant Tells All!
In this week’s episode of On The Pen Live, guest Scott Liberto of PlanetScott.com joins to discuss his experience in the Survodutide clinical trial.
Survodutide is an investigational dual agonist targeting both the glucagon and GLP-1 receptors, developed by Boehringer Ingelheim in collaboration with Zealand Pharma. This novel drug is designed to treat obesity and metabolic dysfunction-associated steatohepatitis (MASH).
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro
📲 Contact Me: MounjaroMan@gmail.com
👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen
📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
TRUMP: Ozempic Will Soon be $150 in the US! Meet the Reporter Who Made Him Say It!
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro
#Zepbound #releasethevials #mounjaro
📲 Contact Me: MounjaroMan@gmail.com 👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen
📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
Threats to Lilly's Zepbound & Mounjaro Printing Press
SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro
#Zepbound #Maritide #mounjaro
📲 Contact Me: MounjaroMan@gmail.com 👉 Link to other GLP-1 MUST HAVE products I mention: https://www.amazon.com/shop/manonthemounjaroonthepen
📼 PLAYLISTS: 🖊️ ON THE PEN LIVES: https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM 👀 WATCH MY MOUNJARO JOURNEY IN ORDER: https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO 😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS: https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW 🚨📰 ALL THE LATEST MOUNJARO NEWS: https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro
SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro
#Zepbound #Maritide #mounjaro
LINKS Life Update Blog: Link: https://www.onthepen.com/post/i-m-tired-we-are-tired
Wegovy released in Canada: Link: https://www.msn.com/en-ca/health/other/weight-loss-drug-wegovy-available-in-canada-starting-may-6/ar-AA1o1lZz
Madison Muller at Bloomberg (friend of our community) had article "Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply" Link: https://www.bloomberg.com/news/articles/2024-05-02/why-weight-loss-drugs-wegovy-zepbound-are-facing-shortages?srnd=undefined&embedded-checkout=true
Interviewed on radio station KXEL Link: https://www.youtube.com/watch?v=V0YyMwtMuxs
FTC is challenging Novo Nordisk's patents on Ozempic Link: https://www.ftc.gov/system/files/ftc_gov/pdf/novo-nordisk-ozempic-saxenda-victoza-_4302024.pdf
FTC requested additional information on Novo Nordisk's acquisition of Catalent: Link: https://www.msn.com/en-us/money/markets/us-ftc-seeks-more-information-on-novo-nordisk-parent-catalent-deal/ar-AA1o6gHU
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.